bioMérieux S.A. (LON: 0RUG)
London flag London · Delayed Price · Currency is GBP · Price in EUR
117.09
+0.16 (0.13%)
At close: Jan 31, 2025

bioMérieux Revenue

bioMérieux had revenue of 1.90B EUR in the half year ending June 30, 2024, with 14.71% growth. This brings the company's revenue in the last twelve months to 3.81B, up 2.85% year-over-year. In the year 2023, bioMérieux had annual revenue of 3.67B with 2.39% growth.

Revenue (ttm)
3.81B EUR
Revenue Growth
+2.85%
P/S Ratio
n/a
Revenue / Employee
272.24K EUR
Employees
13,982
Market Cap
11.56B GBP

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.67B85.60M2.39%
Dec 31, 20223.59B212.90M6.31%
Dec 31, 20213.38B258.00M8.27%
Dec 31, 20203.12B443.40M16.58%
Dec 31, 20192.67B253.50M10.47%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 38.20B
Shell 227.10B
HSBC Holdings 43.25B
Unilever 51.12B
Rio Tinto Group 42.87B
RELX PLC 9.30B
British American Tobacco p.l.c. 26.18B
BP p.l.c. 144.69B
Revenue Rankings